Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Ecancermedicalscience|October 5, 2020
Early molecular response in East African Philadelphia chromosome-positive chronic myeloid leukaemia patients treated with Imatinib and barriers to access treatmentOliver Henke, Priscus John Mapendo, Elifuraha Wilson Mkwizu, et al.
Pain|March 26, 2014
Inhibition of c-Kit signaling is associated with reduced heat and cold pain sensitivity in humansMarta Ceko, Nevena Milenkovic, Philipp le Coutre, et al.
European Journal of Haematology|November 15, 2002
Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemiaMichaela Schwarz, Karl-Anton Kreuzer, Gökben Baskaynak, et al.
Haematologica|October 14, 2003
Safety and efficacy of stem cell mobilization under imatinib therapyKarl-Anton Kreuzer, Christine Klühs, Michaela Schwarz, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
NilotinibBenjamin N Ostendorf, Philipp le Coutre, Theo D Kim, et al.
Leukemia & Lymphoma|May 24, 2012
Off-target effects of BCR-ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemiaJuan Luis Steegmann, Francisco Cervantes, Philipp le Coutre, et al.
Virchows Archiv : an International Journal of Pathology|September 15, 2005
Unusual sarcomatoid neoplasm of the lung suggesting a myofibrosarcomaLars Morawietz, Cornelius Kuhnen, Detlef Katenkamp, et al.
Leukemia Research|January 22, 2005
Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CMLIl-Kang Na, Karl-Anton Kreuzer, Joachim Lupberger, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Cetuximab: appraisal of a novel drug against colorectal cancerBert Hildebrandt, Philipp le Coutre, Annett Nicolaou, et al.
British Journal of Haematology|December 23, 2003
Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purgingKarl-Anton Kreuzer, Christine Klühs, Gökben Baskaynak, et al.
Pageof 11